Lesley Fallowfield - Overview
Development and Evaluation of Training Materials and an Intervention to Help Healthcare Professionals explain Randomised Clinical Trials for Cancer Therapy
Aims and objectives to:
- examine preferences of both patients and the public towards descriptions of randomisation.
- produce training videos and handbook
- improve communication of clinicians and when discussing trials
- evaluate training package in an RCT
- increase patients' understanding of trials.
The Development of Workshops to Promote Effective Communication within the Multidisciplinary Team
Aims to:
- develop and measure acceptability of training intervention for MDTs
- examine multidisciplinary team members' expectations of their own and each others roles in providing information
- assess the overall strengths and weaknesses of the team
- improve communication between team members
- audit patients’ satisfaction with service
- produce recommendations of MDT training needs to trusts and DoH
Other research
UKCTOCS is a 10 year project investigating the behavioural, psychosocial and psychosexual implications of ovarian cancer screening to postmenopausal women aged 50 to 74 in the general population.
RAZOR is a pilot project to determine the feasibility of an RCT of treatment with Zoladex plus Raloxifene in comparison with no medical treatment for the reduction in breast cancer. We are assessing the impact that participation has on the quality of life of women at high genetic risk.
INTERGROUP EXEMESTANE TRIAL is multicentre, study measuring the quality of life in postmenopausal women with primary breast cancer who have received adjuvant tamoxifen for 2-3 years and are then randomised to receive either exemestane or further tamoxifen. The study utilises the FACT-ES endocrine subscale developed and validated by us.
ALMANAC Axillary clearance or axillary node sample is a standard part of the surgical management of invasive breast cancer. For many women the procedure is unnecessary and results in significant morbidity. The new technique of sentinel node biopsy could make 60-70% of all axillary staging operations redundant, we are conducting an RCT of the procedure.
COGNITION AND SERMS Development of a pragmatic cognitive assessment package to establish the minimum amount of testing that permits reliable detection of possible cognitive changes in women who are receiving selective oestrogen receptor modulators (SERMs) for the prevention or treatment of breast cancer.
